NCT02844842View on ClinicalTrials.gov

"Evaluation of Tolerability and Safety of Allergovac Poliplus in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice"

CompletedOBSERVATIONAL
Enrollment

152

Participants

Timeline

Start Date

November 23, 2016

Primary Completion Date

September 6, 2018

Study Completion Date

September 6, 2018

Conditions
Allergic RhinitisRhinoconjunctivitisAsthma
Interventions
BIOLOGICAL

Allergovac Poliplus

Trial Locations (15)

Unknown

C.H.U A Coruña, A Coruña

Hopsital de Vinalopó, Elche

Clínica Dr. Arias Irigoyen, Huelva

Clínica Dra. Victoria Moreno, Huelva

Hospital de Lugo, Lugo

Clínica de Asma y Alergia Dres. Ojeda, Madrid

Hospital Principe de Asturias, Madrid

Hospital Puerta de Hierro, Madrid

Hospital de Onteniente, Ontinyent

Hospital de Tórax, Santa Cruz de Tenerife

Hospital Ntra. Sra de la Candelaria, Santa Cruz de Tenerife

Hospital Joan XXIII, Tarragona

Hospital de Terrassa, Terrassa

Hospital de Manises, Valencia

Hospital de Xátiva, Xátiva

All Listed Sponsors
lead

Roxall Medicina España S.A

INDUSTRY

NCT02844842 - "Evaluation of Tolerability and Safety of Allergovac Poliplus in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice" | Biotech Hunter | Biotech Hunter